TSX-V:LOVE - TSX Venture Exchange - CA13765U2002 - Common Stock - Currency: CAD
TSX-V:LOVE (4/23/2025, 7:00:00 PM)
1.34
-0.06 (-4.29%)
The current stock price of LOVE.CA is 1.34 CAD. In the past month the price decreased by -1.47%. In the past year, price increased by 59.52%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
JWEL.CA | JAMIESON WELLNESS INC | 19.22 | 1.29B | ||
GENX.CA | GENIX PHARMACEUTICALS CORP | N/A | 2.07M |
Cannara Biotech, Inc. engages in the production of premium-grade cannabis and cannabis-derivative products. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2019-01-14. The firm operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. The company owns two mega cultivation facilities based in Quebec spanning over 1,650,000 square feet, providing the Company with 100,000 kilograms of annualized cultivation output. The company operates in two segments: Cannabis operations and Real estate operations. The Cannabis operations encompass the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market. The Real estate operations is related to the Farnham and Valleyfield building. The firm's brand portfolio includes Tribal, Nugz, and Orchid CBD. Tribal delivers grade cannabis products. Orchid CBD is a wellness brand that provides CBD-rich cannabis.
CANNARA BIOTECH INC
Suite 2050 - 1055, West Georgia Street
Vancouver BRITISH COLUMBIA V6E 3P3 CA
Employees: 13
Company Website: https://www.cannara.ca/en/
Investor Relations: http://investors.cannara.ca/financials/financial-reports/
Phone: 15149139136.0
The current stock price of LOVE.CA is 1.34 CAD. The price decreased by -4.29% in the last trading session.
The exchange symbol of CANNARA BIOTECH INC is LOVE and it is listed on the TSX Venture Exchange exchange.
LOVE.CA stock is listed on the TSX Venture Exchange exchange.
CANNARA BIOTECH INC (LOVE.CA) has a market capitalization of 122.52M CAD. This makes LOVE.CA a Micro Cap stock.
CANNARA BIOTECH INC (LOVE.CA) currently has 13 employees.
CANNARA BIOTECH INC (LOVE.CA) has a support level at 1.31 and a resistance level at 1.38. Check the full technical report for a detailed analysis of LOVE.CA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
LOVE.CA does not pay a dividend.
CANNARA BIOTECH INC (LOVE.CA) will report earnings on 2025-04-25.
The PE ratio for CANNARA BIOTECH INC (LOVE.CA) is 19.14. This is based on the reported non-GAAP earnings per share of 0.07 and the current share price of 1.34 CAD. Check the full fundamental report for a full analysis of the valuation metrics for LOVE.CA.
ChartMill assigns a technical rating of 9 / 10 to LOVE.CA. When comparing the yearly performance of all stocks, LOVE.CA is one of the better performing stocks in the market, outperforming 93.58% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to LOVE.CA. The financial health of LOVE.CA is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months LOVE.CA reported a non-GAAP Earnings per Share(EPS) of 0.07. The EPS decreased by -28.67% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 7.56% | ||
ROA | 4.12% | ||
ROE | 7.33% | ||
Debt/Equity | 0.44 |